Remnant cholesterol is an effective biomarker for predicting survival in patients with breast cancer
Jinyu Shi(Capital Medical University), Hanping Shi(Beijing Shijitan Hospital), Li Deng(Sichuan University), Hailun Xie(Guangxi Medical University), Xin Zheng(Union Hospital), Heyang Zhang(Academy of Military Medical Sciences), Guo‐Tian Ruan(Beijing Friendship Hospital), Xiaowei Zhang(Xuzhou Medical College), Qi Zhang(Peking University), Tong Liu(Southeast University), Yue Chen(Capital Medical University), Xiangrui Li(Institute of Plant Protection), Xiaoyue Liu(Zhejiang University), Chenan Liu(Hunan University of Technology), Shiqi Lin(Nanjing University of Information Science and Technology)
Cited by 11
Related Papers
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations
|Cancer Discovery|2017|457
Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study
|Frontiers in Immunology|2023|189
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
|Journal of Cachexia Sarcopenia and Muscle|2022|170
A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment
|Journal of Neuroinflammation|2020|167
A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer
|Frontiers in Endocrinology|2022|161